Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA)

"Sf. Pantelimon Emergency Clinical Hospital", Bucharest

Kharkiv Medical Academy of Postgraduate Education, Department of Cardiology and Functional Diagnostics, Clinical Facility: City Clinical Hospital #8, Kharkiv

Public Institution O.I. Minakov City Clinical Hospital #9, Rheumatology Department, Odesa

"Zaporizhya State Medical University, Department of Internal Diseases #2, Clinical facility: Medical and Sanitary Unit within the State-Owned Company Radioprylad", Zaporizhya

Danylo Halytsky Lviv National Medical University, Department of Clinical Immunology and Allergology, Clinical Facility: Lviv Regional Clinical Hospital, Rheumatology Department, Lviv

Danylo Halytsky Lviv National Medical University, Department of Internal Diseases #2, Dermatology and Venerology within the Faculty of Continuing Education, Clinical facility: City Clinical Hospital #4, Rheumatology Department, Lviv

M. Gorky National Medical University, Donetsk

V.K. Gusak Institute of Urgent & Reconstructive Surgery within the Academy of Medical Sciences of Ukraine, Hospital Therapy and Rehabilitation Clinic, Donetsk

SC Excentric Company SRL, Rheumatology Department, Timișoara

Cluj Emergency County Clinical Hospital Rheumatology Department, Cluj-Napoca

Brasov Clinical County Emergency Hospital Rheumatology Department, Brasov

Targu-Mures County Clinical Hospital Rheumatology Department, Târgu Mureş

Rehabilitation Hospital, Rheumatology Department, Iași

"Dr. Carol Davila Central Military Emergency Clinical Hospital", Bucharest

Sana Medical Center, Bucharest

"Sf. Maria Clinical Hospital, Department of Internal Medicine and Rheumatology", Bucharest

Kyiv City Oleksandrivska Clinical Hospital, Rheumatology Department #2, Kyiv

O.O. Bogomolets National Medical University, Department of Internal Diseases Propedeutics #2, Clinical facility: City Clinical Hospital #3, Kyiv